• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Model Number 1550350-18
Medical Device Problem Code Material Separation (1562)
Health Effect - Clinical Code No Information (3190)
Date of Event 09/10/2020
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The device was received.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.
 
Event or Problem Description
It was reported that a 3.5x18mm xience sierra drug eluting stent (des) was returned to the returns good lab (rg) with a hand written ¿stent broke¿ on a yellow post-it note.A quick visual inspection noted that the proximal portion of the hypotube was separated, including the hub.Blood was noted on and inside of the device and the balloon had been partially inflated.The stent was deployed but not returned with the device.There were no reported adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
 
Additional Manufacturer Narrative
The device was returned for analysis.The reported material separations were able to be confirmed.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other similar incidents from this lot.Based on the condition of the returned device being consistent with preparation and advancement onto the guide wire, it is possible the reported/noted device damages occurred during use; however due to the limited amount of case details the investigation determined a conclusive cause for the reported/noted device damages cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.Na.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Common Device Name
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key10968983
Report Number2024168-2020-10266
Device Sequence Number2322698
Product Code NIQ
UDI-Device Identifier08717648227424
UDI-Public08717648227424
Combination Product (Y/N)Y
Initial Reporter StateAR
Initial Reporter CountryUS
PMA/510(K) Number
P110019
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/24/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date12/08/2021
Device Model Number1550350-18
Device Catalogue Number1550350-18
Device Lot Number0060242
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/17/2020
Initial Date Received by Manufacturer 11/17/2020
Supplement Date Received by Manufacturer12/09/2020
Initial Report FDA Received Date12/08/2020
Supplement Report FDA Received Date12/24/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age66 YR
-
-